Biotech investment intelligence

Biotech catalysts, clearly tracked.

Upcoming trial readouts, clinical pipelines and FDA milestones across a growing universe of biotech companies — updated daily from public data.

View catalyst calendar Browse companies

Next catalysts

All →
Upcoming readouts
BEAM2026-12BEAM2026-12CRNA.OL2027-05CRSP2027-06CRNA.OL2027-06CRSP2027-06VRTX2027-06VRTX2027-06
ExpectedCompanyPhaseIndication
2026-12 BEAM Unspecified Sickle Cell Trait
2026-12 BEAM Phase 1/2 Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia
2027-05-19 CRNA.OL Phase 1/2 Multiple Myeloma, Smoldering Multiple Myeloma
2027-06 CRSP Phase 1 Cardiovascular, Metabolic Disease, Dyslipidemias
2027-06 CRNA.OL Phase 2 Pancreatic Ductal Adenocarcinoma, Refractory Non-Small Cell Lung Cancer
2027-06-06 CRSP Phase 3 Sickle Cell Disease, Hydroxyurea Failure, Hydroxyurea Intolerance
2027-06-09 VRTX Phase 3 Beta-Thalassemia, Thalassemia, Hematologic Diseases
2027-06-30 VRTX Phase 3 Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia

Tracked companies

All →
CRSP CRISPR Therapeutics 9 trials NTLA Intellia Therapeutics 7 trials BEAM Beam Therapeutics 8 trials MRNA Moderna 1 trials VRTX Vertex Pharmaceuticals 13 trials CRNA.OL Circio Holding ASA 3 trials CRNO-B.ST Cereno Scientific AB 1 trials

Pipeline snapshot

Full pipeline →
Trials by phase
Phase 1/211Phase 311Unspecified6Phase 26Phase 14Phase 2/32Phase 42
11Phase 1/2
11Phase 3
6Unspecified
6Phase 2
4Phase 1
2Phase 2/3
2Phase 4